Novelgen
Find Us
← Back to list

One of Europe’s leading VCs banks a €725M ‘crossover’ fund

BioPharma DiveGwendolyn WuNovember 16, 2026
Sofinnova Partners, which has backed the likes of successful drugmakers such as Abivax, Argenx and Verona Pharma, will use the cash to support a new group of later-stage biotechs.
Read original article
← Back to list